IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Velan Capital Investment Management LP

Q3 2024 Holdings

Filed 2024-11-14 | 20 holdings | $106.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Jasper Therapeutics Inc(JSPR)COM NEW471871202$27.0M1,433,82825.2%
Praxis Precision Medicines I(PRAX)COM NEW74006W207$20.2M350,66618.9%
Spdr SER TR(XBI)CallS&P BIOTECH78464A870$14.8M150,00013.9%
Heron Therapeutics Inc(HRTX)COM427746102$13.9M6,986,74413.0%
Tourmaline BIO Inc(TRML)COM89157D105$8.5M331,1908.0%
Rezolute Inc(RZLT)COM NEW76200L309$3.9M800,0003.6%
Liquidia Corporation(LQDA)COM NEW53635D202$3.0M300,0002.8%
Context Therapeutics Inc(CNTX)COM21077P108$2.5M1,290,3232.4%
Inspiremd Inc(NSPR)COM45779A846$2.4M904,0292.3%
Scpharmaceuticals Inc(SCPH)COM810648105$2.4M517,6682.2%
Tela BIO Inc(TELA)COM872381108$1.9M747,4101.8%
Optinose IncCOM68404V100$1.4M2,146,6081.3%
Zevra Therapeutics Inc(ZVRA)COM NEW488445206$1.4M200,0001.3%
Protara Therapeutics Inc(TARA)COM STK74365U107$1.1M574,0001.0%
Corbus Pharmaceuticals Hldgs(CRBP)COM NEW21833P301$1.0M50,0001.0%
Skye Bioscience Inc(SKYE)COM NEW83086J200$825.3K211,0710.8%
Kiora Pharmaceuticals Inc(KPRX)COM49721T507$447.3K122,2230.4%
Tenax Therapeutics Inc(TENX)COM NEW88032L605$288.3K83,3330.3%